Tom Meade DM FRCP FFPH FinstMed FRS
- Tom Meade's Contacts
- Room 265
- Keppel Street
- WC1E 7HT
- T: +44 (0)20 7927 2182
- F: +44 (0)20 7580 6897
Tom Meade qualified in medicine from Oxford University in 1960. After house and registrar appointments at Barts and in Oxford, he spent a year at the Schieffelin Leprosy Research Sanatorium in South India on clinical and epidemiological aspects of leprosy. In 1970, he was appointed Director of the MRC Epidemiology and Medical Care Unit which was responsible for a range of biomedical and health service research topics. His main personal interest has been the role of the coagulation system in the development of coronary heart disease (CHD), approached through epidemiological studies of the association of clotting factors with CHD and through clinical trials of antithrombotic measures. It was for this work that he was elected a Fellow of the Royal Society (FRS) in 1996.
On the health services research side, the Unit made original and significant contributions on unglamorous, but important and previously neglected topics such as incontinence, low back pain, alcohol abuse and disability.
On his retirement, from the MRC in 2001, Tom Meade transferred to the London School of Hygiene & Tropical Medicine as Emeritus Professor where he has continued to work on cardiovascular disease.
Role of coagulation system in thrombotic component of coronary heart disease. Trials of antithrombotic agents. Infection and coronary heart disease.
- Clinical trials
- Randomised controlled trials
Disease and Health Conditions
- Cardiovascular disease
- Euro area
- United Kingdom
- Cancer Registration
- Cancer Survival
- Medical research
- NCDs-Intervention Research
- clinical epidemiology
The Northwick Park Heart Study: Evidence from the Laboratory.
Ten Cate, H.; Meade, T.;
J Thromb Haemost, 2014; 12(5):587-92
Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents.
Meade, T. ;
Handb Exp Pharmacol, 2012; (210):565-605
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Rothwell, P.M.; Fowkes, F.G.R.; Belch, J.F.F.; Ogawa, H.; Warlow, C.P.; Meade, T.W.
Lancet, 2011; 377(9759):31-41
Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database.
Clayton, T.C.; Gaskin, M.; Meade, T.W.;
Int J Epidemiol, 2011; 40(3):819-27
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.
dos Santos Silva, I.; De Stavola, B.L.; Pizzi, C.; Meade, T.W.;
Int J Epidemiol, 2010; 39(3):699-709
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Rothwell, P.M.; Wilson, M.; Elwin, C.E.; Norrving, B.; Algra, A.; Warlow, C.P.; Meade, T.W.;
Lancet, 2010; 376(9754):1741-50
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Antithrombotic Trialists' (ATT) Collaboration; Baigent, C. ; Blackwell, L. ; Collins, R. ; Emberson, J. ; Godwin, J. ; Peto, R. ; Buring, J. ; Hennekens, C. ; Kearney, P. ; Meade, T. ; Patrono, C. ; Roncaglioni, M.C. ; Zanchetti, A. ;
Lancet, 2009; 373(9678):1849-60
Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.
Bartlett, J.W.; De Stavola, B.L.; Meade, T.W.;
J Thromb Haemost, 2008; 7(2):270-6
- → View all Tom Meade 's publications